Albany - New York, Sept. 29, 2016 -- TMR finds that the various opportunities in the global cell culture market will propel the expansion of the market at a CAGR of 7.1% during the period from 2014 to 2022. This would lead to an increase in the valuation of the market from US$6.1 bn in 2013 to US$11.3 bn in 2022.
Browse Industry Research Report with free Analysis: http://www.transparencymarketresearch.com/cell-culture-market.html
The vendor landscape in the global cell culture market includes players such as VWR International LLC, Thermo Fisher Scientific Inc., GE Healthcare, Lonza Group Ltd., Becton, Dickinson & Co., Sigma-Aldrich Co. LLC., Corning Life Sciences B.V., EMD Millipore, PromoCell GmbH, and Wheaton Industries Inc. According to a TMR analyst, mergers and acquisitions among the key players are expected to strengthen the market in the coming years.
Cell Culture Consumables Register Higher Demand than Serums and Reagents
The market players are registering increased demand for cell culture across the medical research sector. Cell cultures are being increasingly applied across drug screening and monitoring, disease diagnosis, biologic manufacturing, IVF technology, cancer research, and stem cell research. Increased investments by private medical organizations and government organizations have supported the growth of the global cell culture market. TMR states that among the cell culture consumables, cell culture media register the highest demand compared to serums and reagents. This is due to the key importance of the nature of the culture medium to the health of the cells.
3D Cell Culture to Define Future of Global Cell Culture Market
The growing demand for biopharmaceuticals and artificial organs, coupled with the emerging trend towards serum-free, customized and specialty media solutions is the primary factor contributing towards the growth of the global cell culture market. The increasing focus on stem cell research would further expand the scope of the market in future. TMR recommends that the focus on backward integration to conduct in-house research and sustaining pricing pressures amid a weak global economic scenario will open up significant opportunities for the market players.
However, ethical concern over the usage of animal sources in cell culture is one of the major restraints in the growth of the market. The usage of transgenic plants and animals, and stringent process controls will also impede the growth of the market in the years to come. “3D cell culture has the potential to serve as the future growth opportunity for the market and in vitro analysis.” a TMR analyst predicts.
Get Research PDF for more Professional and Technical Insights: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405
Asia Pacific to Register Highest Demand for Cell Culture
TMR predicts that among the key regions in the global cell culture market, Asia Pacific will register the fastest growth during the period between 2014 and 2022. “The improvement in economic conditions of the developing countries in the Asia Pacific region such as China and India is anticipated to support the market’s growth,” the analyst states. In 2013, North America was the leading region in the market.
The review is based on the conclusions of a TMR report titled “Cell Culture Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022.”
Browse Press Release on Cell Culture Market: http://www.transparencymarketresearch.com/pressrelease/cell-culture-market.htm
Global cell culture market has been segmented as:
Global Cell Culture Consumables Market
- Media
- Sera
- Reagents
Global Cell Culture Instruments Market
- Culture Systems
- Incubators
- Pipetting Instruments
- Roller Bottle Equipment
- Biosafety Cabinets
- Cryostorage Equipment
- Others
Global Cell Culture Market, by Geography
- North America
- Europe
- Asia Pacific
- Latin America (LATAM)
- Rest of the World (RoW)
Browse Other Research Reports:
- Cell and Tissue Culture Supplies Market: http://www.transparencymarketresearch.com/cell-tissue-culture-supplies-market.html
- Live Cell Imaging (LCI) Market: http://www.transparencymarketresearch.com/live-cell-imaging-market.html
- Cell Culture Media, Sera, and Reagents Market: http://www.transparencymarketresearch.com/cell-culture-media-sera-reagents-market.html
About Us:
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact Us: Rohit Bhisey Transparency Market Research 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com Blog: http://www.tmrblog.com/


CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
First Western Ship Transits Strait of Hormuz Since Iran War Began
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Apple Turns 50: From Garage Startup to AI Crossroads
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers 



